J. Armstrong

发表

NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma

R. Flockhart, N. Reynolds, J. Armstrong, 2009, British Journal of Cancer.

Guidelines for the use and interpretation of assays formonitoring autophagy (3rd edition)

Sangeeta Khare, Xin Qi, Ying Wang, 2016 .

Targeting X-linked inhibitor of apoptosis protein to increase the efficacy of endoplasmic reticulum stress-induced apoptosis for melanoma therapy.

S. Fulda, Shaun Martin, J. Armstrong, 2010, The Journal of investigative dermatology.

Regulation of Glycogen Synthesis by Amino Acids in Cultured Human Muscle Cells*

S. Bonavaud, J. Armstrong, S. Yeaman, 2001, The Journal of Biological Chemistry.

Regulation of Endoplasmic Reticulum Stress-induced Cell Death by ATF4 in Neuroectodermal Tumor Cells*

R. Flockhart, J. Armstrong, P. Lovat, 2009, The Journal of Biological Chemistry.

Targeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis: the role of stress proteins ERdj5 and ERp57

G. Fimia, M. Corazzari, M. Piacentini, 2007, British Journal of Cancer.

Regulation of glycogen synthesis in human muscle cells.

S. Bonavaud, J. Armstrong, S. Yeaman, 2001, Biochemical Society transactions.

Prognostic Impact of p 62 Expression in Cutaneous Malignant Melanoma

S. Horswell, N. Kirkham, J. Armstrong, 2015 .

Endoplasmic Reticulum Stress Disulfide Isomerases to Abrogate Survival Responses to Increasing Melanoma Cell Death Using Inhibitors of Protein

M. Corazzari, V. Pagliarini, M. Piacentini, 2008 .

Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization

F. Goñi, P. Boya, J. Nylandsted, 2016, Autophagy.

Inhibition of CXCR4–CXCL12 chemotaxis in melanoma by AMD11070

R. Plummer, H. Marshall, S. Fricker, 2013, British Journal of Cancer.

Oncogenic B-RAF Signaling in Melanoma Impairs the Therapeutic Advantage of Autophagy Inhibition

G. Fimia, M. Corazzari, V. Pagliarini, 2011, Clinical Cancer Research.

Role of Noxa in p53-independent fenretinide-induced apoptosis of neuroectodermal tumours

J. Armstrong, P. Lovat, G. Veal, 2007, Apoptosis.

Epidermal autophagy and beclin 1 regulator 1 and loricrin: a paradigm shift in the prognostication and stratification of the American Joint Committee on Cancer stage I melanomas†

S. Horswell, N. Reynolds, J. Armstrong, 2019, The British journal of dermatology.

Melanoma secretion of transforming growth factor‐β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration

G. Inman, M. Corazzari, M. Piacentini, 2021, The British journal of dermatology.

13-cis retinoic acid and isomerisation in paediatric oncology--is changing shape the key to success?

J. Armstrong, G. Veal, C. Redfern, 2005, Biochemical pharmacology.

Increasing the therapeutic efficacy of docetaxel for cutaneous squamous cell carcinoma through the combined inhibition of phosphatidylinositol 3‐kinase/AKT signalling and autophagy

J. Armstrong, P. Lovat, M. Birch-Machin, 2013, Clinical and experimental dermatology.

Control of glycogen synthesis by glucose, glycogen, and insulin in cultured human muscle cells.

J. Mccormack, S. Bonavaud, J. Armstrong, 2001, Diabetes.

Prognostic impact of p62 expression in cutaneous malignant melanoma

S. Horswell, S. Tooze, N. Kirkham, 2013, The Journal of investigative dermatology.

Synthesis and CYP26A1 inhibitory activity of novel methyl 3-[4-(arylamino)phenyl]-3-(azole)-2,2-dimethylpropanoates.

A. Brancale, C. Simons, J. Armstrong, 2012, Bioorganic & medicinal chemistry.

Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death.

G. Velasco, M. Corazzari, J. Armstrong, 2015, The Journal of investigative dermatology.

Research Techniques Made Simple: Analysis of Autophagy in the Skin.

N. Reynolds, J. Armstrong, P. Lovat, 2021, The Journal of investigative dermatology.

The Role of the

A. Boddy, C. W. Metz, J. Armstrong, 1934 .

Novel retinoic acid 4-hydroxylase (CYP26) inhibitors based on a 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-(4-(phenylamino)phenyl)propyl scaffold.

A. Brancale, C. Simons, J. Armstrong, 2012, Bioorganic & medicinal chemistry.

Synthesis and biological evaluation of 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propyl derivatives as small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26).

A. Brancale, C. Simons, J. Armstrong, 2011, Journal of medicinal chemistry.

Novel azolyl-(phenylmethyl)]aryl/heteroarylamines: potent CYP26 inhibitors and enhancers of all-trans retinoic acid activity in neuroblastoma cells.

A. Brancale, C. Simons, J. Armstrong, 2008, Bioorganic & medicinal chemistry.

Small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26): synthesis and biological evaluation of imidazole methyl 3-(4-(aryl-2-ylamino)phenyl)propanoates.

A. Brancale, C. Simons, J. Armstrong, 2011, Journal of medicinal chemistry.

The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide.

D. Jamieson, A. Neilson, Shaun Martin, 2011, Oncology reports.

Increasing the intracellular availability of all-trans retinoic acid in neuroblastoma cells

A. Boddy, J. Armstrong, G. Veal, 2005, British Journal of Cancer.

Oncogenic BRAF signalling increases Mcl‐1 expression in cutaneous metastatic melanoma

J. Armstrong, P. Lovat, D. Hill, 2013, Experimental dermatology.

Inhibition of CXCR 4 – CXCL 12 chemotaxis in melanoma by AMD 11070

R. Plummer, H. Marshall, S. Fricker, 2019 .

Combining the Endoplasmic Reticulum Stress–Inducing Agents Bortezomib and Fenretinide as a Novel Therapeutic Strategy for Metastatic Melanoma

R. Flockhart, Shaun Martin, J. Armstrong, 2009, Clinical Cancer Research.

Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress.

M. Corazzari, V. Pagliarini, M. Piacentini, 2008, Cancer research.

A Novel Fully Humanized 3D Skin Equivalent to Model Early Melanoma Invasion

S. Przyborski, Mei Chen, J. Armstrong, 2015, Molecular Cancer Therapeutics.

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

Sara W. Bird, Erinna F. Lee, Michael D. Kim, 2016 .

Bioenergetic cellular index: a clinical biomarker to identify metabolic adaption in melanoma?

J. Armstrong, 2019, British Journal of Dermatology.

Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivo

A. Boddy, J. Armstrong, G. Veal, 2007, British Journal of Cancer.

Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress.

M. Corazzari, M. Piacentini, Shaun Martin, 2008, Cancer research.

Targeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis: the role of stress proteins ERdj5 and ERp57

G. Fimia, M. Corazzari, M. Piacentini, 2007, British Journal of Cancer.

FC2 Oncogenic B-RAF signalling confers the resistance of metastatic melanoma to autophagy

M. Corazzari, M. Piacentini, J. Armstrong, 2010 .